M. Nunez

Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial.

B. Seltzer, R. Goldman, Dinesh Kumar, 2004, Archives of neurology.

Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm.

M. Saad, K. Osei, R. Reinhardt, 2004, Diabetes care.

Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia

L. Webster, J. Tobias, M. Nunez, 2011, BMC anesthesiology.

CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study.

M. Franceschi, G. Bottini, E. Scarpini, 2013, Current Alzheimer research.

Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10

Wei Chen, Mark Lebwohl, James G Krueger, 2017, The Journal of Immunology.

CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo-Controlled Study.

M. Franceschi, G. Bottini, E. Scarpini, 2013, Current Alzheimer research.

High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial.

E. Bedrick, C. Vial, M. Nunez, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.